Bank Of New York Mellon Corp Abeona Therapeutics Inc. Transaction History
Bank Of New York Mellon Corp
- $528 Trillion
- Q2 2024
A detailed history of Bank Of New York Mellon Corp transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 121,453 shares of ABEO stock, worth $715,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121,453
Previous 119,019
2.05%
Holding current value
$715,358
Previous $863 Million
40.32%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ABEO
# of Institutions
57Shares Held
28.4MCall Options Held
827KPut Options Held
44.5K-
Suvretta Capital Management, LLC New York, NY3.69MShares$21.7 Million0.65% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.47MShares$20.4 Million0.98% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.25MShares$19.1 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.68MShares$15.8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$11.5 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $35M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...